SCHEMBL3237258

SCHEMBL3237258

O=C(c1ccccc1)N(CCCc1cccc(C(F)(F)F)c1)C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.51
HDAC8 Q9BY41 2/20 0.48
HDAC1 Q13547 1/20 0.48
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NR4A2 P43354 2/20 0.45
MAPT P10636 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
TACR1 P25103 2/20 0.45
TAAR1 Q96RJ0 1/20 0.44
SLC2A1 P11166 1/20 0.43
CES2 O00748 1/20 0.43
LMNA P02545 1/20 0.43
GPBAR1 Q8TDU6 1/20 0.43
PTGES O14684 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3232453 0.92 TRPM8 (0.53) TRPM8HDAC8HDAC1MEN1KMT2A
SCHEMBL3237382 0.78 PDPK1 (0.52) HDAC8HDAC1MEN1KMT2A
SCHEMBL25337304 0.76 TAAR1 (0.53) HDAC8HDAC1MEN1KMT2ANR4A2
Hydrochloric Acid SCHEMBL25337090 0.75 TAAR1 (0.51) HDAC8HDAC1MEN1KMT2ANR4A2
SCHEMBL11383498 0.74 TAAR1 (0.65) HDAC8HDAC1MEN1KMT2AMAPT
SCHEMBL28423545 0.74 FFAR4 (0.53) TRPM8HDAC8HDAC1MEN1KMT2A
SCHEMBL1981615 0.74 FFAR4 (0.59) HDAC8HDAC1MEN1KMT2AMAPT
SCHEMBL3579012 0.73 TRPM8 (0.47) TRPM8MEN1KMT2AMAPTLMNA
SCHEMBL12040551 0.73 TAAR1 (0.62) HDAC8HDAC1MEN1KMT2AMAPT
SCHEMBL11755472 0.73 HDAC1 (0.60) HDAC8HDAC1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745477-B2 Heteroaryl and benzyl amide compounds HOFFMAN-LA ROCHE INC. (US) 2010-06-29 US disclosed
US-20070185058-A1 Heteroaryl and benzyl amide compounds HOFFMANN-LA ROCHE INC. 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185058-A1 Heteroaryl and benzyl amide compounds CYP1B1, CYP4B1, ABCG2 TRPM8 4398/4885HDAC8 1066/4885HDAC1 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.